RÉSUMÉ
The availability of a range of modified synthetic oligonucleotides from commercial vendors has allowed the development of sophisticated assays to characterize diverse properties of nucleic acid metabolizing enzymes that can be run in any standard molecular biology lab. The use of fluorescent labels has made these methods accessible to researchers with standard PAGE electrophoresis equipment and a fluorescent-enabled imager, without using radioactive materials or requiring a lab designed for the storage and preparation of radioactive materials, i.e., a Hot Lab. The optional addition of standard modifications such as phosphorylation can simplify assay setup, while the specific incorporation of modified nucleotides that mimic DNA damages or intermediates can be used to probe specific aspects of enzyme behavior. Here, the design and execution of assays to interrogate several aspects of DNA processing by enzymes using commercially available synthetic oligonucleotides are demonstrated. These include the ability of ligases to join or nucleases to degrade different DNA and RNA hybrid structures, differential cofactor usage by the DNA ligase, and evaluation of the DNA-binding capacity of enzymes. Factors to consider when designing synthetic nucleotide substrates are discussed, and a basic set of oligonucleotides that can be used for a range of nucleic acid ligase, polymerase, and nuclease enzyme assays are provided.
Sujet(s)
Oligonucléotides , Oligonucléotides/composition chimique , Oligonucléotides/métabolisme , ADN/composition chimique , ADN/métabolisme , DNA ligases/métabolisme , DNA ligases/composition chimique , ARN/composition chimique , ARN/analyse , ARN/métabolismeRÉSUMÉ
The multitarget stool RNA (mt-sRNA) test (ColoSense) is a noninvasive diagnostic test that screens for colorectal cancer and advanced adenomas in average-risk individuals aged 45 years and older. The mt-sRNA test incorporates a commercially available fecal immunochemical test, concentration of eight RNA transcripts, and participant-reported smoking status. As part of the CRC-PREVENT (Colorectal Cancer and Pre-Cancerous Adenoma Non-Invasive Detection Test) clinical trial, 12 analytical validation studies were conducted to assess analytical sensitivity, linearity, precision, interfering substances, cross-reactivity, carry-over, cross-contamination, and robustness. Analytical validation of the mt-sRNA test demonstrated limit of blank, limit of detection, and limit of quantification of <0.6, <0.7, and ≤2.5 copies/µL for all markers, respectively. The mt-sRNA test demonstrated linearity between 2.5 and 2500 copies/µL, and <20% coefficient of variation, and/or ≥95% concordance with regard to precision, interfering substances, carry-over, cross-contamination, and robustness. There was no significant impact of cross-reactivity from non-colorectal cancer diseases. These data provide a framework for laboratories to complete analytical validation for RNA-based panels that require premarket approval as a class III medical device from the US Food and Drug Administration.
Sujet(s)
Marqueurs biologiques tumoraux , Tumeurs colorectales , Dépistage précoce du cancer , Fèces , Humains , Tumeurs colorectales/diagnostic , Tumeurs colorectales/génétique , Dépistage précoce du cancer/méthodes , Fèces/composition chimique , Adulte d'âge moyen , Marqueurs biologiques tumoraux/génétique , Femelle , Mâle , Reproductibilité des résultats , Sensibilité et spécificité , Sujet âgé , ARN/génétique , ARN/analyse , Limite de détectionRÉSUMÉ
Benzo[a]pyrene-modified oligonucleotides were developed for the detection of RNAs with a point mutation. The probes produced two distinct fluorescence signals in response to single nucleotide differences in the RNA sequences, allowing for discrimination between the matched and single base mismatched RNA sequences in colorimetric and ratiometric manners.
Sujet(s)
Benzo[a]pyrène , Colorants fluorescents , Mutation ponctuelle , ARN , Benzo[a]pyrène/analyse , Benzo[a]pyrène/composition chimique , ARN/génétique , ARN/composition chimique , ARN/analyse , Colorants fluorescents/composition chimique , Colorimétrie , Spectrométrie de fluorescence , Oligonucléotides/composition chimiqueRÉSUMÉ
G-quadruplex (G4), an unconventional nucleic acid structure, shows polymorphism in its topological morphology. The parallel G4 topology is the most prevalent form in organisms and plays a regulatory role in many biological processes. Designing fluorescent probes with high specificity for parallel G4s is important but challenging. Herein, a supramolecular assembly of the anionic cyanine dye SCY-5 is reported, which selectively identifies parallel G4 topology. SCY-5 can clearly distinguish parallel G4s from other G4s and non-G4s, even including hybrid-type G4s with parallel characteristics. The high specificity mechanism of SCY-5 involves a delicate balance between electrostatic repulsion and π-π interaction between SCY-5 and G4s. Using SCY-5, cellular RNA extracted from peripheral venous blood was quantitatively detected, and a remarkable increase in RNA G4 content in cancer patients compared to healthy volunteers was confirmed for the first time. This study provides new insights for designing specific probes for parallel G4 topology and opens a new path for clinical cancer diagnosis using RNA G4 as a biomarker.
Sujet(s)
Carbocyanines , Colorants fluorescents , G-quadruplexes , Tumeurs , Humains , Carbocyanines/composition chimique , Colorants fluorescents/composition chimique , Tumeurs/diagnostic , ARN/composition chimique , ARN/analyseRÉSUMÉ
Disease diagnostics and surveillance increasingly highlight the importance of portable, cost-effective, and sensitive point-of-care (POC) detection of nucleic acids. Here, we report a CRISPR/Cas13a-responsive and RNA-bridged DNA hydrogel capillary sensor for the direct and visual detection of specific RNA with high sensitivity. The capillary sensor was simply prepared by loading RNA-cross-linking DNA hydrogel film (â¼0.2 mm ± 0.02 mm) at the end of a capillary. When CRISPR/Cas13a specifically recognizes the target RNA, the RNA bridge in the hydrogel film is cleaved by the trans-cleavage activity of CRISPR/Cas13a, increasing the permeability of the hydrogel film. Different concentrations of target RNA activate different amounts of Cas13a, cleaving different amounts of the RNA bridge in the hydrogel and causing corresponding changes in the permeability of the hydrogel. Therefore, samples containing different amounts of the target RNA travel to different distances in the capillary. Visual reading of the distance provides quantitative detection of the RNA target without the need for any nucleic acid amplification or auxiliary equipment. The technique was successfully used for the determination of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA in clinical nasopharyngeal (NP) swab and saliva samples. Easily quantifiable distance using a ruler eliminates the need for any optical or electrochemical detection equipment, making this assay potentially useful for POC and on-site applications.
Sujet(s)
Systèmes CRISPR-Cas , ADN , Hydrogels , SARS-CoV-2 , Humains , Hydrogels/composition chimique , ADN/composition chimique , ADN/analyse , SARS-CoV-2/génétique , SARS-CoV-2/isolement et purification , Systèmes automatisés lit malade , ARN viral/analyse , Techniques de biocapteur , COVID-19/diagnostic , COVID-19/virologie , ARN/analyseRÉSUMÉ
8-oxoguanine (o8G), a prevalent oxidative modification in RNA induced by reactive oxygen species (ROS), plays a pivotal role in regulating RNA functions. Accurate detection and quantification of o8G modifications is critical to understanding their biological significance and potential as disease biomarkers, but effective detection methods remain limited. Here, we have developed a highly specific T3 DNA ligase-dependent qPCR assay that exploits the enzyme's ability to discriminate o8G from guanine (G) with single-nucleotide resolution. This method can detect o8G in RNA at levels as low as 500 fM, with an up to 18-fold higher selectivity for discriminating o8G from G. By simulating oxidative stress conditions in SH-SY5Y and HS683 cell lines treated with rotenone, we successfully identified site-specific o8G modifications in key miRNAs associated with neuroprotective responses, including miR-124, let-7a and miR-29a. The developed assay holds significant promise for the practical identification of o8G, facilitating its potential for detailed studies of o8G dynamics in various biological contexts and diseases.
Sujet(s)
Guanine , Guanine/analogues et dérivés , Guanine/composition chimique , Guanine/métabolisme , Humains , ARN/métabolisme , ARN/analyse , microARN/analyse , microARN/métabolisme , DNA ligases/métabolisme , Lignée cellulaire tumorale , Stress oxydatif , Réaction de polymérisation en chaine en temps réelRÉSUMÉ
This analysis uses data from 2 studies to explore whether lowering the threshold for fecal immunochemical test positivity can achieve comparable levels of sensitivity and specificity as multitarget stool RNA testing for colorectal cancer screening.
Sujet(s)
Tumeurs colorectales , Dépistage précoce du cancer , Fèces , Tumeurs colorectales/diagnostic , Tumeurs colorectales/génétique , Humains , Fèces/composition chimique , Dépistage précoce du cancer/méthodes , Sang occulte , Immunochimie , ARN/analyseRÉSUMÉ
Transcription is the primary regulatory step in gene expression. Divergent transcription initiation from promoters and enhancers produces stable RNAs from genes and unstable RNAs from enhancers1,2. Nascent RNA capture and sequencing assays simultaneously measure gene and enhancer activity in cell populations3. However, fundamental questions about the temporal regulation of transcription and enhancer-gene coordination remain unanswered, primarily because of the absence of a single-cell perspective on active transcription. In this study, we present scGRO-seq-a new single-cell nascent RNA sequencing assay that uses click chemistry-and unveil coordinated transcription throughout the genome. We demonstrate the episodic nature of transcription and the co-transcription of functionally related genes. scGRO-seq can estimate burst size and frequency by directly quantifying transcribing RNA polymerases in individual cells and can leverage replication-dependent non-polyadenylated histone gene transcription to elucidate cell cycle dynamics. The single-nucleotide spatial and temporal resolution of scGRO-seq enables the identification of networks of enhancers and genes. Our results suggest that the bursting of transcription at super-enhancers precedes bursting from associated genes. By imparting insights into the dynamic nature of global transcription and the origin and propagation of transcription signals, we demonstrate the ability of scGRO-seq to investigate the mechanisms of transcription regulation and the role of enhancers in gene expression.
Sujet(s)
Éléments activateurs (génétique) , Régulation de l'expression des gènes , Régions promotrices (génétique) , ARN , Analyse de séquence d'ARN , Analyse de l'expression du gène de la cellule unique , Transcription génétique , Animaux , Humains , Souris , Cycle cellulaire/génétique , Chimie click/méthodes , DNA-directed RNA polymerases/analyse , DNA-directed RNA polymerases/métabolisme , Éléments activateurs (génétique)/génétique , Régulation de l'expression des gènes/génétique , Histone/métabolisme , Régions promotrices (génétique)/génétique , ARN/analyse , ARN/biosynthèse , ARN/génétique , Analyse de séquence d'ARN/méthodes , Analyse de l'expression du gène de la cellule unique/méthodes , Facteurs tempsRÉSUMÉ
The methylation modifications of adenosine, especially N6-methyladenosine (m6A) and N6, 2'-odimethyladenosine (m6Am), play vital roles in various biological, physiological, and pathological processes. However, current methods for detecting these modifications at single-base resolution have limitations. Mass spectrometry (MS), a highly accurate and sensitive technique, can be utilized to differentiate between m6A and m6Am by analyzing the molecular weight differences in their fragments during tandem MS analysis. In this study, we present an MS-based method that allows for the simultaneous determination of m6A and m6Am sites in targeted RNA fragments at single-nucleotide resolution. The approach involves the utilization of tandem MS in conjunction with targeted RNA enrichment and enzymatic digestion, eliminating the need for PCR amplification. By employing this strategy, we can accurately identify m6A and m6Am sites in targeted RNA fragments with high confidence. To evaluate the effectiveness of our method, we applied it to detect m6A and m6Am sites in cell and tissue samples. Furthermore, we verified the accuracy of our approach by performing CRISPR/Cas9-mediated knockout of the corresponding methyltransferases. Overall, our MS-based method offers a reliable and precise means for the simultaneous detection of m6A and m6Am modifications in targeted RNA fragments, providing valuable insights into the functional characterization of these modifications in various biological contexts.
Sujet(s)
Adénosine , ARN , Adénosine/analyse , Adénosine/analogues et dérivés , ARN/analyse , ARN/génétique , Humains , Méthylation , Methyltransferases/métabolisme , Methyltransferases/génétique , Spectrométrie de masse en tandem/méthodes , AnimauxRÉSUMÉ
The analysis of RNA sequences is crucial to obtain invaluable insights into disease prognosis. Reliable and rapid diagnostic solutions at the site of sample collection contribute toward optimal delivery of medical treatment. For this reason, the development of more sensitive and portable RNA detection techniques are expected to advance current point-of-care (POC) diagnostic capabilities. Advancements of POC diagnostic technologies will also contribute to counter the spread of emerging viruses. Reverse transcriptase polymerase chain reaction (RT-PCR) is the most commonly used technique to identify etiological organisms of infections. However, the need for thermocycler and fluorescent measurement renders RT-PCR less suitable for POC applications. Here, we provide a step-by-step protocol of Nucleic Acid Sequence-Based Amplification (NASBA), a robust isothermal RNA amplification technique, coupled with a portable paper microfluidics detection format.
Sujet(s)
Microfluidique , Papier , ARN viral , Humains , ARN viral/génétique , ARN viral/analyse , Microfluidique/méthodes , Microfluidique/instrumentation , Réplication de séquence auto-entretenue/méthodes , Systèmes automatisés lit malade , ARN/analyse , ARN/génétiqueRÉSUMÉ
RNA in situ hybridization reveals the abundance and location of gene expression in cells or tissues, providing a technical basis for the clinical diagnosis of diseases. In this chapter, we show a "V" shape probe-mediated single-molecule chromogenic in situ hybridization (vsmCISH) technique for bright-field visualization of individual RNA molecules. In our method, several pairs of target hybridization probes are hybridized to RNA molecules and each probe pair forms a "V" shape overhang. The overhang oligonucleotides then mediated the proximity ligation to form DNA circles, followed by rolling circle amplification for signal enhancement and enzyme-catalyzed chromogenic reaction-based readout. The colorimetric assay avoids problems such as photobleaching and autofluorescence of current fluorescent in situ hybridization-based single-molecule RNA detection techniques. Furthermore, the relatively straightforward protocol makes the method useful for biological research and clinical diagnosis applications.
Sujet(s)
Hybridation in situ , ARN , Hybridation in situ/méthodes , ARN/génétique , ARN/analyse , Humains , Réactifs chromogènes/composition chimique , Colorimétrie/méthodes , Imagerie de molécules uniques/méthodesRÉSUMÉ
Oligonucleotide probe tagging and reverse transcriptase polymerase-chain reaction (RT-PCR) are the most widely used techniques currently used for detecting and analyzing RNA. RNA detection using labeled oligonucleotide probe-based approaches is suitable for point-of-care (POC) applications but lacks assay sensitivity, whereas RT-PCR requires complex instrumentation. As an alternative, immunoassay detection formats coupled with isothermal RNA amplification techniques have been proposed for handheld assay development. In this chapter, we describe a robust technique comprising of: (a) target RNA tagging with a complementary oligonucleotide probe labeled with a hapten moiety to form a DNA/RNA duplex hybrid; (b) complexing the DNA/RNA duplex with a pre-coated antibody (Ab) directed at the hapten moiety; (c) sandwich complex formation with an Ab that selectively recognizes the DNA/RNA structural motif; and (d) detection of the sandwich complex using a secondary Ab enzyme conjugate targeting the anti-DNA/RNA Ab followed by standard enzyme-linked immunosorbent assay (ELISA) visualization.
Sujet(s)
Test ELISA , ARN , ARN/analyse , ARN/génétique , Test ELISA/méthodes , Humains , Dosage immunologique/méthodes , Sondes oligonucléotidiques/composition chimique , Sondes oligonucléotidiques/génétique , Anticorps/immunologie , Hybridation d'acides nucléiques/méthodes , ADN/analyseRÉSUMÉ
Northern blotting (NB) has been a long-standing method for RNA detection. However, its labor-intensive nature, reliance on high-quality RNA, and use of radioactivity have diminished its appeal over time. Nevertheless, the emergence of microRNAs (miRNAs) has reignited the demand for sensitive and quantitative NB techniques. We have recently developed cost-effective and rapid protocols for RNA detection using solid and liquid hybridization (LH) techniques which exhibit high sensitivity without the need for radioactive or specialized reagents like locked nucleic acid (LNA) probes. Our assays incorporate biotinylated probes and improved techniques for probe hybridization, transfer, cross-linking, and signal enhancement. We demonstrate that while NB is sensitive in detecting mRNAs and small RNAs, our LH protocol efficiently detects these as well as miRNAs at lower amounts of RNA, achieving higher sensitivity comparable to radiolabeled probes. Compared to NB, LH offers benefits of speed, sensitivity, and specificity in detecting mRNAs, small RNAs, and miRNAs.
Sujet(s)
microARN , Hybridation d'acides nucléiques , Hybridation d'acides nucléiques/méthodes , microARN/génétique , microARN/analyse , Technique de Northern/méthodes , ARN/génétique , ARN/analyse , ARN messager/génétique , ARN messager/analyse , HumainsRÉSUMÉ
The utilization of drug delivery systems, such as lipid nanoparticles and polyplexes/micelleplexes, has shown promise in intracellularly delivering nucleic acids for addressing various diseases. Accurate quantification of the nucleic acid cargo within nanoparticles is essential for the development of safe and effective nanomedicines. Currently, the RiboGreen and SYBR Gold methods are regarded as standard techniques for the precise quantification of RNA in lipid nanoparticles and polyplexes/micelleplexes, respectively. In this chapter, we present a comprehensive protocol for the precise evaluation of the encapsulation efficiency in such formulations using these methods. Additionally, we offer detailed instructions for nanoparticle preparation, characterization, and a comparative analysis of the sensitivity of both methods in quantifying unencapsulated siRNA.
Sujet(s)
Nanoparticules , ARN , Nanoparticules/composition chimique , ARN/analyse , ARN/composition chimique , Colorants fluorescents/composition chimique , Petit ARN interférent/génétique , Petit ARN interférent/composition chimique , Spectrométrie de fluorescence/méthodesRÉSUMÉ
RNA (ribonucleic acid) plays a crucial role in various cellular processes and is involved in the development and progression of several diseases. RNA molecules have gained considerable attention as potential biomarkers for various ailments, as they reflect the activity of genes in a particular cell or tissue. By measuring the levels of specific RNA molecules, such as messenger RNA (mRNA), noncoding RNAs, including microRNAs (miRNAs), and long noncoding RNAs (lncRNAs), researchers can infer the expression patterns of genes associated with a particular disease. Aberrant expression of specific miRNAs or lncRNAs has been associated with conditions such as cancer, cardiovascular diseases, neurodegenerative disorders, and more. Detection and quantification of these RNAs in biological samples, such as blood or tissue, can provide valuable diagnostic or prognostic information. Yet their analysis is a challenging endeavor due to their length, sequence similarity across family members, sensitivity to disintegration, and low quantity in total samples. New advances in nanophotonics have provided novel options for fabrication of quantum dots (QDs)-based biosensing devices capable of detecting a variety of disease-specific RNAs. Thus, we proposed and designed a nanophotonic method employing oligonucleotide-conjugated quantum dot nanoconjugates for the rapid and accurate detection of RNAs. Despite the abundance of other molecules in the sample, the approach delivers highly selective, precise identification of the target RNAs. The data also indicated the method's great practicality and simplicity in determining RNAs selectively. Overall, the approach enables the evaluation of RNA expression in relation to the initial onset and progression of a human health disorder.
Sujet(s)
Boîtes quantiques , Boîtes quantiques/composition chimique , Humains , microARN/génétique , microARN/analyse , ARN/génétique , ARN/analyse , Techniques de biocapteur/méthodes , ARN messager/génétique , ARN messager/analyse , ARN long non codant/génétique , ARN long non codant/analyseRÉSUMÉ
Rapid and sensitive RNA detection is of great value in diverse areas, ranging from biomedical research to clinical diagnostics. Existing methods for RNA detection often rely on reverse transcription (RT) and DNA amplification or involve a time-consuming procedure and poor sensitivity. Herein, we proposed a CRISPR/Cas12a-enabled amplification-free assay for rapid, specific, and sensitive RNA diagnostics. This assay, which we termed T7/G4-CRISPR, involved the use of a T7-powered nucleic acid circuit to convert a single RNA target into numerous DNA activators via toehold-mediated strand displacement reaction and T7 exonuclease-mediated target recycling amplification, followed by activating Cas12a trans-cleavage of the linker strands inhibiting split G-Quadruplex (G4) assembly, thereby inducing fluorescence attenuation proportion to the input RNA target. We first performed step-by-step validation of the entire assay process and optimized the reaction parameters. Using the optimal conditions, T7/G4-CRISPR was capable of detecting as low as 3.6 pM target RNA, obtaining â¼100-fold improvement in sensitivity compared with the most direct Cas12a assays. Meanwhile, its excellent specificity could discriminate single nucleotide variants adjacent to the toehold region and allow species-specific pathogen identification. Furthermore, we applied it for analyzing bacterial 16S rRNA in 40 clinical urine samples, exhibiting a sensitivity of 90% and a specificity of 100% when validated by RT-quantitative PCR. Therefore, we envision that T7/G4-CRISPR will serve as a promising RNA sensing approach to expand the toolbox of CRISPR-based diagnostics.
Sujet(s)
Systèmes CRISPR-Cas , G-quadruplexes , Systèmes CRISPR-Cas/génétique , Humains , Exodeoxyribonucleases/métabolisme , Exodeoxyribonucleases/composition chimique , ARN/analyse , ARN/métabolisme , Techniques d'amplification d'acides nucléiques , Protéines associées aux CRISPR/métabolisme , Protéines bactériennes , EndodeoxyribonucleasesRÉSUMÉ
RNA sequence information holds immense potential as a drug target for diagnosing various RNA-mediated diseases and viral/bacterial infections. Massively parallel complementary DNA (c-DNA) sequencing helps but results in a loss of valuable information about RNA modifications, which are often associated with cancer evolution. Herein, we report machine learning (ML)-assisted high throughput RNA sequencing with inherent RNA modification detection using a single-molecule, long-read, and label-free quantum tunneling approach. The ML tools achieve classification accuracy as high as 100% in decoding RNA and 98% for decoding both RNA and RNA modifications simultaneously. The relationships between input features and target values have been well examined through Shapley additive explanations. Furthermore, transmission and sensitivity readouts enable the recognition of RNA and its modifications with good selectivity and sensitivity. Our approach represents a starting point for ML-assisted direct RNA sequencing that can potentially decode RNA and its epigenetic modifications at the molecular level.
Sujet(s)
Épigenèse génétique , Apprentissage machine , ARN , Analyse de séquence d'ARN , ARN/génétique , ARN/analyse , ARN/composition chimique , Analyse de séquence d'ARN/méthodes , Théorie quantique , Séquençage nucléotidique à haut débit , HumainsRÉSUMÉ
RNA is a key biochemical marker, yet its chemical instability and complex secondary structure hamper its integration into DNA nanotechnology-based sensing platforms. Relying on the denaturation of the native RNA structure using urea, we show that restructured DNA/RNA hybrids can readily be prepared at room temperature. Using solid-state nanopore sensing, we demonstrate that the structures of our DNA/RNA hybrids conform to the design at the single-molecule level. Employing this chemical annealing procedure, we mitigate RNA self-cleavage, enabling the direct detection of restructured RNA molecules for biosensing applications.
Sujet(s)
ADN , Nanopores , ARN , ARN/composition chimique , ARN/analyse , ADN/composition chimique , Techniques de biocapteur/méthodes , Conformation d'acide nucléique , Hybridation d'acides nucléiques , Nanotechnologie/méthodes , Urée/composition chimiqueRÉSUMÉ
Staining frozen sections is often required to distinguish cell types for spatial transcriptomic studies of the brain. The impact of the staining methods on the RNA integrity of the cells becomes one of the limitations of spatial transcriptome technology with microdissection. However, there is a lack of systematic comparisons of different staining modalities for the pretreatment of frozen sections of brain tissue as well as their effects on transcriptome sequencing results. In this study, four different staining methods were analyzed for their effect on RNA integrity in frozen sections of brain tissue. Subsequently, differences in RNA quality in frozen sections under different staining conditions and their impact on transcriptome sequencing results were assessed by RNA-seq. As one of the most commonly used methods for staining pathological sections, HE staining seriously affects the RNA quality of frozen sections of brain tissue. In contrast, the homemade cresyl violet staining method developed in this study has the advantages of short staining time, low cost, and less RNA degradation. The homemade cresyl violet staining proposed in this study can be applied instead of HE staining as an advance staining step for transcriptome studies in frozen sections of brain tissue. In the future, this staining method may be suitable for wide application in brain-related studies of frozen tissue sections. Moreover, it is expected to become a routine step for staining cells before sampling in brain science.
Sujet(s)
Encéphale , Coupes minces congelées , Coloration et marquage , Animaux , Encéphale/métabolisme , Coloration et marquage/méthodes , Coupes minces congelées/méthodes , Cryo-ultramicrotomie/méthodes , Souris , Transcriptome , Mâle , ARN/analyse , Benzoxazines , Souris de lignée C57BL , OxazinesRÉSUMÉ
Biobanks of cervical screening (LBC) samples annotated with disease status are an invaluable resource to support the development of tools for the risk stratification of disease. Although there is growing interest in the assessment of RNA-based biomarkers, little is known on the suitability and durability of stored clinical samples (commonly used in cervical screening) to support RNA-based research. RNA was extracted from 260 stored LBC samples. Storage at -80°C or -25°C allowed isolation of sufficient RNA for further analysis. RNA was found to be substantially degraded according to Agilent Bioanalyser data. Despite this, RT-qPCR was successful in 95% samples tested. These data suggest that biobanked LBC samples are suitable for RNA-based assessment even if stored for up to 14 years.
RNA was extracted from 260 cervical screening samples stored at either -80 or -25°C. An Agilent Bioanalyser was used to examine the level of degradation of a convenience sample of RNAs. Reverse transcriptase quantitative PCR (RT-qPCR) was used to quantify levels of two cellular mRNAs in all samples as a practical means of assessing suitability of the samples for mRNA biomarker analysis.